Published date: 30 September 2020
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Research and development services and related consultancy services - 73000000
Location of contract
England
Value of contract
£90,000
Procurement reference
4415/Tender/
Published date
30 September 2020
Closing date
31 May 2020
Closing time
12am
Contract start date
1 June 2020
Contract end date
31 July 2020
Contract type
Service contract
Procedure type
Call-off from a framework agreement
A mini-competition or direct purchase from a pre-established framework agreement.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
NHS England & Improvement (NHSE&I) require visibility of the medicines supply chain and national stockholding of priority ICU medicines. Such information supports NHSE&I to allocate and distribute medicines equitably, based on need, to NHS Trusts in England and across the devolved administrations. An understanding of national stock holdings allows us to plan for shortages, manage shortages and engage with industry on areas for priority manufacture. Several medicines are in extremely high demand and the profile of use has changed: COVID-19 treatment requires far higher volumes of certain medicines per patient compared to BAU treatment - primarily due to the length of sedation needed.
More information
Additional text
-
n/a
Award information
Awarded date
28 May 2020
Contract start date
1 June 2020
Contract end date
31 July 2020
Total value of contract
£90,000
This contract was awarded to 1 supplier.
ERNST & YOUNG LLP
Address
1 More London Place, London, SE1 2AF
Reference
No reference - other
Value of contract
£90,000
Supplier is SME?
No
Supplier is VCSE?
No
Additional details
-
MCF2 Framework Lot 4.
About the buyer
Contact name
Commercial Team
Address
Wellington House, Waterloo
133-155 Waterloo Rd, Lambeth
SE18UG
England
Share this notice
Closing: 31 May 2020, 12am
All content is available under the
